LSI Medience Corporation and its 100% subsidiary, LSIM Safety Institute Corporation provide seamless services from non-clinical testing to clinical trials as a drug development support.
LSIM Safety Institute conducts various safety studies including high level pharmacological efficacy and pharmacokinetic studies for application for regulatory approval with our thoroughly equipped facility that has been audited and certified for pharmaceutical, medical device, cellular and tissue-based product, agricultural chemical, and Chemical Substances Control Law GLPs. In addition to pharmaceuticals and cellular and tissue-based products, our expertise lies in contract testing services for development of food products, new chemical substances, and agricultural chemicals, as well as preparation of application documents and provision of laboratory technique education.
In the stage of clinical development, LSI Medience provides two distinctive services: bioanalysis services and central laboratory services. Our GLP compliant laboratory provides advanced analytical technology in the field of special testing such as biomarker and drug concentration analysis. Our experienced researchers offer consistent support on studies ranging from method development and validation all the way to actual analysis. Additionally, our wide range of analytical instruments and large library of validated analytical methods allow us to support our clients’ research in a multitude of ways.
We also provide a series of central laboratory services related to clinical testing such as delivery of sample collection kits to medical institutions as well as sample pick-up upon request. Our customized kit design and dedicated sample pick-up network for clinical trials sample are well-established and have built up a great reputation over 25 years. These services are managed under our dedicated IT system to support clinical trials. We do our best to implement smooth and efficient project management based on our extensive experience and clinical trial know-how.